EyePoint Pharmaceuticals
EYPT
#6195
Rank
C$1.44 B
Marketcap
C$17.18
Share price
-2.25%
Change (1 day)
19.54%
Change (1 year)

Earnings for EyePoint Pharmaceuticals (EYPT)

Earnings in 2026 (TTM): -C$0.38 Billion

According to EyePoint Pharmaceuticals 's latest financial reports the company's current earnings are C$7.61 Million. In 2025 the company made an earning of -C$0.33 Billion a decrease over its 2024 earnings that were of -C$0.2 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for EyePoint Pharmaceuticals from 2003 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -C$0.38 Billion14.11%
2025 -C$0.33 Billion63.24%
2024 -C$0.2 Billion104.29%
2023 -C$97.9 Million-29.88%
2022 -C$0.14 Billion87.2%
2021 -C$74.58 Million38.58%
2020 -C$53.82 Million-24.56%
2019 -C$71.33 Million
2017 -C$32.54 Million22.59%
2016 -C$26.54 Million-8.02%
2015 -C$28.86 Million-296.09%
2014 C$14.71 M-174.02%
2013 -C$19.88 Million37.42%
2012 -C$14.47 Million-56.29%
2011 -C$33.1 Million-1062.38%
2010 C$3.43 M-250.43%
2009 -C$2.29 Million-89.5%
2008 -C$21.78 Million
2005 -C$13.43 Million56.99%
2004 -C$8.56 Million73.7%
2003 -C$4.93 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Nymox Pharmaceutical
NYMX
-C$3.05 Million-99.20% Bahamas
NRC Health
NRC
C$27.64 M-107.26%๐Ÿ‡บ๐Ÿ‡ธ USA